BGM Group Ltd.
BGM · Pharmaceutical Preparations
Latest available SEC filing: 20-F ·
Latest disclosures
-
Latest financial period: Q3 2025
Financial facts · Filed
-
Form 20-F
SEC filing · Filed
-
ren yuehua: Form 3
Insider disclosure · Filed · Report period 31 Mar 2026
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- BGM · G7307E123 - Class A Ordinary Share, par value $0.00833335 per share
Company details and SEC sources
CIK 0001779578 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- BGM on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- No. 152 Hongliang East 1 St Street, No. 1703, Tianfu New District, Chengdu, 0000
- Incorporated in
- Cayman Islands
- Fiscal year end
- 30 September
- Former names on EDGAR
- Qilian International Holding Group (to 22 Oct 2024), Qilian International Holding Group Ltd (to 16 Oct 2024)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields